Literature DB >> 21827557

Framework Convention on Tobacco Control (FCTC) Article 14 guidelines: a new era for tobacco dependence treatment.

Martin Raw.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21827557     DOI： 10.1111/j.1360-0443.2011.03536.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  5 in total

Review 1.  Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Authors:  Henri-Jean Aubin; Amandine Luquiens; Ivan Berlin
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

2.  Cessation behaviours among smokers of menthol and flavoured cigarettes following the implementation of the EU Tobacco Products Directive: findings from the EUREST-PLUS ITC Europe Surveys.

Authors:  Mateusz Zatoński; Aleksandra Herbeć; Witold Zatoński; Kinga Janik-Koncewicz; Pete Driezen; Tibor Demjén; Esteve Fernández; Geoffrey T Fong; Anne C K Quah; Christina N Kyriakos; Ann McNeill; Marc Willemsen; Ute Mons; Yannis Tountas; Antigona C Trofor; Constantine I Vardavas; Krzysztof Przewoźniak
Journal:  Eur J Public Health       Date:  2020-07-01       Impact factor: 3.367

Review 3.  Research priorities for Article 14--demand reduction measures concerning tobacco dependence and cessation.

Authors:  Hayden McRobbie; Martin Raw; Sophia Chan
Journal:  Nicotine Tob Res       Date:  2012-11-08       Impact factor: 4.244

4.  Smokeless tobacco cessation interventions: A systematic review.

Authors:  Suzanne Tanya Nethan; Dhirendra Narain Sinha; Kumar Chandan; Ravi Mehrotra
Journal:  Indian J Med Res       Date:  2018-10       Impact factor: 2.375

5.  An observational study of system-level changes to improve the recording of very brief advice for smoking cessation in an inpatient mental health setting.

Authors:  Gilda Spaducci; Sol Richardson; Ann McNeill; Megan Pritchard; Jyoti Sanyal; Andy Healey; Mary Yates; Debbie Robson
Journal:  BMC Public Health       Date:  2020-04-25       Impact factor: 3.295
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.